29 September 2020: Clinical Research
HMGA1 Promotes Hepatic Metastasis of Colorectal Cancer by Inducing Expression of Glucose Transporter 3 (GLUT3)
Meijing Yang 1ABC* , Yang Guo 1DE* , Xiaoyun Liu 2E , Naiqing Liu 3ABCDEF*DOI: 10.12659/MSM.924975
Med Sci Monit 2020; 26:e924975
Table 1 Basic characteristics of patients with CRCLM.
| Factors | Number | Percentage |
|---|---|---|
| Sex | ||
| Male | 29 | 39.73% |
| Female | 44 | 60.27% |
| Age | 0 | |
| 15 | 20.55% | |
| ≥60 | 58 | 79.45% |
| Differentiation | 0 | |
| Good | 44 | 60.27% |
| Moderate+poor | 29 | 39.73% |
| Lymph node invasion | 0 | |
| No (N0) | 46 | 63.01% |
| Yes (N1/2) | 27 | 36.99% |
| Number of CRCLM | 0 | |
| 38 | 52.05% | |
| ≥3 | 35 | 47.95% |
| CRCLM distribution | 0 | |
| Unilobar | 46 | 63.01% |
| Bilobar | 27 | 36.99% |
| HMGA1 | ||
| Low | 39 | 53.42% |
| High | 34 | 46.58% |
| GLUT3 | ||
| Low | 37 | 50.68% |
| High | 36 | 49.32% |